ConcertAI
Cambridge
About ConcertAI
ConcertAI is a developer of medical research tool suite intended to design and deliver care-based oncology research and data analytics. It is an integrated real-world data and AI-driven solutions to transform how insights are generated and accelerate therapeutic innovations to patients. It was incorporated in 2018 and is based in Boston, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $300.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Mar 2022)
- Website: concertai.com
- Phone: [email protected]
Industries & Categories
Analytics, Artificial Intelligence (AI), Biotechnology, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/concertai-117833 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.